Autori: Kalebasty Arash Rezazadeh
| Naslov | FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis. (Meeting Abstract) |
| Autori | Siefker-Radtke Arlene O Currie Graeme Abella Esteban Vaena Daniel A Kalebasty Arash Rezazadeh Curigliano Giuseppe Tupikowski Krzysztof Andric Zoran G Lugowska Iwona Kelly William Kevin |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2019), vol. 37 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
